These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 26686256)

  • 1. Efficacy and safety of thalidomide for the treatment of severe recurrent epistaxis in hereditary haemorrhagic telangiectasia: results of a non-randomised, single-centre, phase 2 study.
    Invernizzi R; Quaglia F; Klersy C; Pagella F; Ornati F; Chu F; Matti E; Spinozzi G; Plumitallo S; Grignani P; Olivieri C; Bastia R; Bellistri F; Danesino C; Benazzo M; Balduini CL
    Lancet Haematol; 2015 Nov; 2(11):e465-73. PubMed ID: 26686256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of thalidomide therapy for refractory epistaxis in hereditary haemorrhagic telangiectasia: systematic review.
    Harrison L; Kundra A; Jervis P
    J Laryngol Otol; 2018 Oct; 132(10):866-871. PubMed ID: 30191780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalidomide for Epistaxis in Patients with Hereditary Hemorrhagic Telangiectasia: A Preliminary Study.
    Fang J; Chen X; Zhu B; Ye H; Zhang W; Guan J; Su K
    Otolaryngol Head Neck Surg; 2017 Aug; 157(2):217-221. PubMed ID: 28418273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia.
    Al-Samkari H; Kasthuri RS; Iyer VN; Pishko AM; Decker JE; Weiss CR; Whitehead KJ; Conrad MB; Zumberg MS; Zhou JY; Parambil J; Marsh D; Clancy M; Bradley L; Wisniewski L; Carper BA; Thomas SM; McCrae KR
    N Engl J Med; 2024 Sep; 391(11):1015-1027. PubMed ID: 39292928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep vein thrombosis induced by thalidomide to control epistaxis secondary to hereditary haemorrhagic telangiectasia.
    Penaloza A; Vekemans MC; Lambert C; Hermans C
    Blood Coagul Fibrinolysis; 2011 Oct; 22(7):616-8. PubMed ID: 21885956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalidomide for the Management of Bleeding Episodes in Patients with Hereditary Hemorrhagic Telangiectasia: Effects on Epistaxis Severity Score and Quality of Life.
    Baysal M; Ümit EG; Kırkızlar HO; Özdöver AC; Demir AM
    Turk J Haematol; 2019 Feb; 36(1):43-47. PubMed ID: 29880465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Timolol in a Novel Intranasal Thermosensitive Gel for Hereditary Hemorrhagic Telangiectasia-Associated Epistaxis: A Randomized Clinical Trial.
    Peterson AM; Lee JJ; Kallogjeri D; Schneider JS; Chakinala MM; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2020 Nov; 146(11):1006-1014. PubMed ID: 32940653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia: A Randomized Clinical Trial.
    Whitehead KJ; Sautter NB; McWilliams JP; Chakinala MM; Merlo CA; Johnson MH; James M; Everett EM; Clancy MS; Faughnan ME; Oh SP; Olitsky SE; Pyeritz RE; Gossage JR
    JAMA; 2016 Sep; 316(9):943-51. PubMed ID: 27599329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of TIMOLOL nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia. A double-blind, randomized, placebo-controlled trial.
    Dupuis-Girod S; Pitiot V; Bergerot C; Fargeton AE; Beaudoin M; Decullier E; Bréant V; Colombet B; Philouze P; Faure F; Letievant JC
    Sci Rep; 2019 Aug; 9(1):11986. PubMed ID: 31427745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia.
    Buscarini E; Botella LM; Geisthoff U; Kjeldsen AD; Mager HJ; Pagella F; Suppressa P; Zarrabeitia R; Dupuis-Girod S; Shovlin CL;
    Orphanet J Rare Dis; 2019 Feb; 14(1):28. PubMed ID: 30717761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of bleeding gastro-intestinal angiodysplasia in hereditary haemorrhagic telangiectasia with thalidomide.
    Alam MA; Sami S; Babu S
    BMJ Case Rep; 2011 Nov; 2011():. PubMed ID: 22674103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic surgical treatment of epistaxis in hereditary haemorrhagic telangiectasia: our experience.
    Pagella F; Pusateri A; Maiorano E; Spinozzi G; Ugolini S; Lizzio R; Mirabella R; Tinelli C; Olivieri C; Matti E
    Acta Otorhinolaryngol Ital; 2021 Feb; 41(1):59-68. PubMed ID: 33746224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A natural obturator in hereditary haemorrhagic telangiectasia.
    Soni-Jaiswal A; Woolford TJ
    J Laryngol Otol; 2009 Jun; 123(6):695-6. PubMed ID: 19275781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coblation for epistaxis management in patients with hereditary haemorrhagic telangiectasia: a multicentre case series.
    Joshi H; Woodworth BA; Carney AS
    J Laryngol Otol; 2011 Nov; 125(11):1176-80. PubMed ID: 21846415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical treatment of epistaxis in hereditary hemorrhagic telangiectasia: an evidence-based review.
    Halderman AA; Ryan MW; Clark C; Sindwani R; Reh DD; Poetker DM; Invernizzi R; Marple BF
    Int Forum Allergy Rhinol; 2018 Jun; 8(6):713-728. PubMed ID: 29393992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic bevacizumab for the treatment of chronic bleeding in hereditary haemorrhagic telangiectasia.
    Al-Samkari H; Kritharis A; Rodriguez-Lopez JM; Kuter DJ
    J Intern Med; 2019 Feb; 285(2):223-231. PubMed ID: 30191646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bortezomib, thalidomide, dexamethasone, and panobinostat for patients with relapsed multiple myeloma (MUK-six): a multicentre, open-label, phase 1/2 trial.
    Popat R; Brown SR; Flanagan L; Hall A; Gregory W; Kishore B; Streetly M; Oakervee H; Yong K; Cook G; Low E; Cavenagh J;
    Lancet Haematol; 2016 Dec; 3(12):e572-e580. PubMed ID: 27843120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based management of epistaxis in hereditary haemorrhagic telangiectasia.
    Syed I; Sunkaraneni VS
    J Laryngol Otol; 2015 May; 129(5):410-5. PubMed ID: 25736077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective pilot study of Floseal® for the treatment of anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT).
    Lee JM; Wu V; Faughnan ME; Lasso A; Figol A; Kilty SJ
    J Otolaryngol Head Neck Surg; 2019 Oct; 48(1):48. PubMed ID: 31615556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thalidomide for hereditary haemorrhagic telangiectasia.
    Franchini M; Lippi G
    Lancet Haematol; 2015 Nov; 2(11):e457-8. PubMed ID: 26686252
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.